Glucose-dependent insulinotropic polypeptide analogues and their therapeutic potential for the treatment of obesity-diabetes
- 19 July 2003
- journal article
- review article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 308 (2) , 207-213
- https://doi.org/10.1016/s0006-291x(03)01361-5
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Evidence that the major degradation product of glucose-dependent insulinotropic polypeptide, GIP(3-42), is a GIP receptor antagonist in vivoJournal of Endocrinology, 2002
- Long-Term Treatment With the Dipeptidyl Peptidase IV Inhibitor P32/98 Causes Sustained Improvements in Glucose Tolerance, Insulin Sensitivity, Hyperinsulinemia, and β-Cell Glucose Responsiveness in VDF (fa/fa) Zucker RatsDiabetes, 2002
- The entero-insular axis in type 2 diabetes - incretins as therapeutic agentsExperimental and Clinical Endocrinology & Diabetes, 2001
- Dipeptidyl Peptidase IV Inhibition Reduces the Degradation and Clearance of GIP and Potentiates Its Insulinotropic and Antihyperglycemic Effects in Anesthetized PigsDiabetes, 2001
- NH2-terminally modified gastric inhibitory polypeptide exhibits amino-peptidase resistance and enhanced antihyperglycemic activity.Diabetes, 1999
- Functional GIP Receptors Are Present on AdipocytesEndocrinology, 1998
- Gastric inhibitory polypeptide and effects of glycation on glucose transport and metabolism in isolated mouse abdominal muscleJournal of Endocrinology, 1998
- Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV.Endocrinology, 1995
- Effect of the entero-pancreatic hormones, gastric inhibitory polypeptide and glucagon-like polypeptide-1(7–36) amide, on fatty acid synthesis in explants of rat adipose tissueJournal of Endocrinology, 1991
- Actions of GIPPeptides, 1981